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Abstract-Descarboxyprothrombin
(PIVKA II) is a precursor of prothrombin without biological activity, and it increases with vitamin K deficiency.
We studied the time course changes in liver and plasma levels of PIVKA II during the progress of vitamin K deficiency in rats. Good correlation was observed between liver PIVKA II and plasma PIVKA II and between liver or plasma PIVKA II and plasma prothrombin in experiments in which rats were fed a vitamin K-deficient diet. Feeding of a vitamin K-deficient diet or fasting caused marked increases in liver and plasma PIVKA II in male rats and a weaker response in female rats. Warfarin, a vitamin K antagonist, caused an abrupt increase in liver PIVKA II, but the increase in plasma PIVKA II was delayed about 3 hr. Plasma prothrombin decreased from about 30 min later. Factor VII decreased similarly to prothrombin, and changes in the prothrombin time and activated partial thromboplastin time were slower than the changes in these substances.
Sex differences were not seen in these warfarin actions.
These observations indicate that liver and plasma PIVKA II are sensitive markers of vitamin K deficiency in rats, and assay of PIVKA II can be useful for analyzing the action mechanism of drugs which influence blood coagulation.
Vitamin K is required in higher animals to regulate the synthesis of prothrombin and three other plasma-clotting factors, VII, IX and X. These clotting factors are synthesized from biologically inactive precursor proteins (PIVKA: protein induced by vitamin K absence or antagonists) by r-glutamyl carboxylase in liver microsomes (1). As these reactions show no progress in the absence of vitamin K or upon treatment with vitamin K antagonists, an increase in PIVKA reflects the liver state of this vitamin. The precursor protein of prothrombin, descarboxypro thrombin (PIVKA II), is easily excreted into the plasma in humans (2) and cattle (3), but is difficult to excrete in rats (4, 5). Recently, certain cephalosporin antibiotics have been reported to cause vitamin K-responsive hypo thrombinemia in some patients (6-9). We studied the assay method of PIVKA II in the liver and plasma and studied the relationships between liver and plasma PIVKA II in rats fed a vitamin K-deficient diet or administered warfarin, a vitamin K antagonist. Prothrombin concentration, factor VII, prothrombin time (PT) and activated partial thromboplastin time (APTT) were determined in some ex periments.
Materials and Methods

Hypothrombinemia
was induced in 7 to 8-week-old Sprague-Dawley rats by feeding them a vitamin K-deficient diet (TEKLAD) or by i.p. Injection of warfarin. Rats were kept in cages with wire netting on the bottom to prevent coprophagy.
Venous blood was collected from the postcava in a 10% volume of 3.8% sodium citrate under Somnopentyl anesthesia (0.5 ml/kg, i.p.: pentobarbital Na, 32.4 mg/kg). The blood specimens were centrifuged at 3,000xg at 4'C for 15 min, and plasma samples were drawn and stored at -20°C until assay. Liver specimens were removed and stored at -70°C. BaCl2 is used to remove pro thrombin instead of insoluble barium salts. In the assay, 25 icl of 25% sodium citrate is added to 1 ml of the plasma with mixing; then 25 j€I of the plasma is transferred to another tube to assay the total amount of prothrombin and PIVKA II. Next, 50 /el of 1.5 M BaCI2 is added to the remaining plasma with mixing by a vortex for 2 min; then the mixture is centrifuged at about 3,000 x g for 10 min. The supernatant is transferred to another tube. This procedure is performed twice to ensure removal of prothrombin. The treated plasma contains PIVKA II.
Both treated and untreated plasma were diluted 40 and 400-fold in 0.1 M Tris buffer, pH 8.3, containing 0.2% BSA (Buffer A), respectively.
To 100 /dl of the diluted plasma was added 0.8 ml of Buffer A con taining 10 icg of echis carinatus venom and 100 units of Trasylol, and the mixture was preincubated at 37°C for 20 min to convert prothrombin and PIVKA II to a thrombin-like substance. Next, 100 id of 1 mM S-2238, a chromogenic substrate, was added, and the mixture was incubated at 37°C for 10 min. The reaction was stopped by addition of 100 /cl of 20% sodium dodecyl sulfate, and the amount of p-nitroaniline generated from the substrate was measured spectropho tometrically at 405 nm against a water blank.
Liver PIVKA II was assayed by solubilizing PIVKA II. First, 100 ul of 20% Triton X-100 was added to 1 ml of microsomal suspension, and this mixture was left standing for about 10 min. Next, 100 /cl of the suspension was transferred for protein determination, and the subsequent procedure was the same as that used for the plasma.
The standard curve was prepared with diluted thrombin to 1.0, 0.5, 0.25 and 0.1 unit/ml in Buffer A on log-log paper. The concentrations of prothrombin and PIVKA II were calculated from the standard curve and given as thrombin units per ml or mg liver microsomal protein. Protein was determined by the method of Lowry et al. (10).
PT, APTT and factor VII were assayed with COAG-A-MATE•X2
(Warner Lambert), a photo-optical clot detection system based on a one-stage method, using fresh plasma. Thrombin (Sigma, T-7513), S 2238 (Kabi Diagnostics), echis carinatus venom (Sigma), Trasylol (Bayer) and BSA (Nakarai, fraction V) were used. normal rats, treated twice with BaC12; -A-: rats fed vitamin K-deficient diet, treated once with BaCl2; -A-:
rats fed vitamin K-deficient diet, treated twice with BaCl2: -0-: rats administered warfarin, treated once with BaCl2: -b-: rats administered warfarin, treated twice with BaC12.
2. Effect of feeding a vitamin K-deficient diet on PIVKA II: Figure 3 shows the time course changes in liver PIVKA II, PT and APTT in rats fed a vitamin K-deficient diet for 2 to 10 days. In male rats, marked elevation of liver PIVKA II was observed after 2 days of feeding; then a gradual elevation followed until 4 days, when the level reached a plateau. Prolongation of PT was, however, slight at 2 days of feeding, gradual until 4 days, and then marked.
On the other hand, in female rats, the increase in liver PIVKA II was gradual and prolongation of PT and APTT was slight in 10 days of feeding. Figure 4 shows the correlation between liver PIVKA II and plasma PIVKA II or pro thrombin in rats fed a normal diet and those fed a vitamin K-deficient diet. The correlation coefficients between liver and plasma PIVKA II, liver PIVKA II and plasma prothrombin, and plasma PIVKA II and prothrombin indicated good reciprocity, with the reciprocity being best between liver PIVKA II and plasma prothrombin. 3. Effect of fasting on PIVKA II levels: Table 2 shows the effect of fasting on plasma and liver PIVKA II, plasma prothrombin and PT. Fasting for only a day caused an increase in plasma and liver PIVKA II and a decrease in prothrombin and prolongation of PT in male rats, and there were slight changes in female rats with 2 days of fasting.
4. Effect of warfarin administration on PIVKA II levels: Figure 5 shows Figure 6 shows the results of dose studies on liver PIVKA II, plasma PIVKA II and plasma prothrombin in male rats. There were slight differences between the doses for the maximal levels of plasma and liver PIVKA II and the minimal level of plasma prothrombin, and for the number of hours required to reach these levels, but the duration of their maximal or minimal levels was longer with higher doses. The changes in PT, APTT and factor VII in these experiments are shown in Fig. 7 . The decrease in factor VII was similar to that of prothrombin, but prolongation of PT and APTT was dose-dependent. 
Discussion
Prothrombin content can be determined by a spectrophotometric method (11, 12), by coagulation assay (13) in which thrombin is generated by physiological or non-physio logical activation, and by immunological assay (14). As PIVKA II and prothrombin are activated by treatment with echis carinatus venom, PIVKA II can be determined by pro thrombin assay methods after separation of prothrombin (4, 5, 15, 16). We employed the method of Suttie et al. (private com munication) for plasma PIVKA II. This method is a modification of the spectro photometric method using a chromogenic substrate (5) and differs in that BaCl2 is used instead of BaSO4 to separate prothrombin. Prothrombin may be absorbed on the insoluble barium citrate formed or it may be precipitated by chelation with barium ion.
BaC12 has been used to remove prothrombin by others (17), but detailed data were not given. Our experiments gave good results for differential estimation of PIVKA 11 and pro thrombin. This method is also convenient for routine assay because BaC12 dissolves in water. Plasma and liver samples can be stored in a freezer for at least 1 month until assay. To assay liver PIVKA 11, a microsomal suspension containing Triton X 100 is better than the solubilized extract as assay samples and is also convenient for routine assay. Vitamin K deficiency produces hypopro thrombinemia, and male rats are more sus ceptible to vitamin K deficiency than female rats (18) (19) (20) (21) (22) . In our experiments, even 2 days feeding of a vitamin K-deficient diet or 1 or 2 days fasting caused a marked increase in liver and plasma PIVKA I I as well as a decrease in plasma prothrombin in male rats, suggesting that the pool of vitamin K is very small in male rats. In female rats, only slight changes in these proteins were observed under the same conditions, indicating that they are more resistant to vitamin K deficiency.
Vitamin K-dependent carboxylation of PIVKA II occurs in liver microsomes and requires a hydroquinone form of vitamin K. Liver microsomes have a vitamin K cycle in which the hydroquinone form can be successively converted into its 2,3-epoxide, the quinone form and the hydroquinone form (1). Warfarin is thought to exhibit its anti coagulant action by inhibiting the process from the 2,3-epoxide to the quinone form and from the quinone to the hydroquinone form. Marked changes in plasma prothrombin and liver PIVKA II occurred even 1.5 hr after administration of 1 mg/kg of warfarin. There were slight differences between warfarin doses for changes in plasma levels of PIVKA II and prothrombin and liver levels of PIVKA II until a plateau or minimum was reached and their maximal or minimal values attained, but the duration of the maximal or minimal level was dose-dependent.
These obser vations suggest that complete inhibition of hydroquinone synthesis of vitamin K occurs in a dose range of 1 to 10 mg/kg and also that the turnover of the vitamin K cycle is very quick. No difference between male and female rats was observed for changes in prothrombin, PIVKA II and PT after inhibition of the synthetic pathway of the hydroquinone form in a vitamin K cycle by warfarin adminis tration. This shows that there is no sex difference in hydroquinone consumption and in the responsibility of vitamin K-dependent carboxylation of PIVKA II to the hydro quinone. Therefore, the sex difference in the resistance to vitamin K deficiency seems to be due to a difference in the supply of the hydroquinone.
A possible cause of the difference may be a sex difference in intestinal absorption of vitamin K, which can be inferred from the experimental result that estrogen facilitates intestinal absorption of vitamin K (21) or a sex difference in con sumption of the quinone form of vitamin K through unknown pathways. In spite of the abrupt increase in liver PIVKA II, the rise in the plasma level was very slight until 3 hr after administration of warfarin.
Liver PIVKA II reached a plateau level 6 hr later, but 24 hr was needed to reach the plateau level in the plasma. These time lags between liver and plasma PIVKA II suggest that there may be a threshold for release of PIVKA I I from the liver to the blood.
In rats fed a vitamin K-deficient diet or administered warfarin, the increase in PT or APTT was slower than the changes in PIVKA II and prothrombin.
Increases in PT and APTT were dose-dependent, but slight differ ences were observed for the increase in PIVKA II and the decrease in prothrombin among warfarin dosages from 1 to 10 mg/kg. A living body may have clotting factors to spare, or changes of PT or APTT may not coincide with changes in the clotting factors because they reflect the composite result of plural clotting factors.
In conclusion, increases in plasma and liver PIVKA II sharply reflect the vitamin K deficient status, and the latter is more sensitive than the former in rats. As PIVKA II has a high specificity for vitamin K deficiency, assay of plasma and liver PIVKA II may be useful for analyzing the action mechanism of drugs which have an influence on blood coagulation. Fig. 7 . Dose studies of warfarin on prothrombin time (PT), activated partial thromboplastin time (APTT) and plasma factor VII in male rats. Warfarin was administered i.p. to rats. Each point represents the mean±S.E.M. of 5 rats.
